Respiration Disorders D012120

Diseases [C] » Respiratory Tract Diseases [C08] » Respiration Disorders

Description

Diseases of the respiratory system in general or unspecified or for a specific respiratory disease not available.   MeSH

Subtype Terms (16)

Acute Chest Syndrome
10 drugs (9 approved, 1 experimental)

Altitude Sickness
40 drugs (26 approved, 14 experimental)

Apnea
19 drugs (15 approved, 4 experimental)

Cheyne-Stokes Respiration
2 drugs (1 approved, 1 experimental)

Cough
123 drugs (56 approved, 67 experimental)

Dyspnea
42 drugs (30 approved, 12 experimental)

Hoarseness
2 drugs (1 approved, 1 experimental)

Hyperventilation
1 approved drug

Meconium Aspiration Syndrome
7 drugs (2 approved, 5 experimental)

Mouth Breathing
 

Respiratory Aspiration
27 drugs (25 approved, 2 experimental)

Respiratory Distress Syndrome
194 drugs (106 approved, 88 experimental)

Respiratory Insufficiency
102 drugs (89 approved, 13 experimental)

Sarcoglycanopathies
 

Tachypnea
2 approved drugs

Vocal Cord Dysfunction
16 drugs (11 approved, 5 experimental)


Phase 2 Indicated Drugs (1)

Phase 1 Indicated Drugs (1)


Organization Involved with Phase 1 Indications (7)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.